An international team of doctors led by Joshua Brody, MD, Director of the Lymphoma Immunotherapy Program at The Tisch Cancer ...
An international team of doctors led by Joshua Brody, MD, Director of the Lymphoma Immunotherapy Program at The Tisch Cancer ...
Qartemi is a 'living drug' that has been approved by the Central Drugs Standard Control Organisation (CDSCO) for blood cancer ...
India introduces Qartemi a groundbreaking CAR-T cell therapy to fight advanced blood cancers like B-cell Non-Hodgkin Lymphoma ...
A "living drug" Qartemi has been approved for blood cancer patients in India who suffer from an advanced or relapsed stage of ...
Oct. 17, 2024 — Researchers discovered they could boost survival to 92% for patients with advanced Hodgkin lymphoma by adding the immunotherapy ... Aggressive B-Cell Lymphoma June 19, 2024 ...
Moreover, advancements in immunotherapy, particularly targeting ... dogs diagnosed with this aggressive cancer. Diffuse Large B-Cell Lymphoma (DLBCL): A type of cancer that originates in B-cells ...